38 yr old man with Evng rise of temperature, bsbk and waist pain , preorbital pain tinnitus ear and pain in the gum

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I have all the information needed. Now let me compile a comprehensive clinical answer.

Clinical Analysis: 38-Year-Old Male with Evening Rise of Temperature

Decoding the Presenting Complaints

SymptomClinical Significance
Evening rise of temperatureClassic "undulant fever" pattern
Back/waist pain (bsbk)Lumbar spondylitis / sacroiliitis
Periorbital painCephalgia/sinus involvement or neurobrucellosis
Tinnitus + ear painOtological involvement (neurobrucellosis)
Gum painOropharyngeal involvement / hematogenous spread

Most Likely Diagnosis: BRUCELLOSIS (Undulant Fever)

This constellation is a textbook presentation of acute/subacute brucellosis. The pattern is recognized as one of three classical presentations: "long-lasting fever, misery, and low-back or hip pain in an older person (especially men)".
"Two features recognized in the nineteenth century distinguish brucellosis from other tropical fevers, such as typhoid and malaria: (1) the fever of brucellosis shows an undulating pattern...persists for weeks...followed by relapse; (2) the fever of brucellosis is associated with musculoskeletal symptoms and signs in about one-half of all patients."
  • Harrison's Principles of Internal Medicine 22E (2025)

Why Each Feature Fits

1. Evening Rise of Temperature ("Undulant Fever")
  • Brucellosis is nicknamed undulant fever because of its remittent, wave-like fever pattern - often peaking in the evenings with drenching night sweats.
  • Fever > 39.4°C occurs in 95% of patients; a relative bradycardia (pulse-temperature dissociation) may also be present.
2. Back and Waist Pain
  • Osteoarticular involvement occurs in ~40% of cases.
  • Sacroiliitis is the most common acute presentation; lumbar spondylitis/spondylodiscitis in the lumbar area is the next most frequent.
  • In endemic areas, a man with fever + difficulty walking is suspected to have brucellosis until proven otherwise.
  • Goldman-Cecil notes: "Among osteoarticular complications, sacroiliitis is the most common acute presentation."
3. Periorbital Pain
  • Ocular pain and blurring of vision occur in a subset of patients, representing either direct orbital/ocular brucellosis or part of neurobrucellosis.
  • Up to 10% of men develop epididymo-orchitis; similarly, genitourinary and neurological spread is well documented.
4. Tinnitus and Ear Pain
  • Neurobrucellosis affects the CNS/peripheral nervous system including cranial nerves, causing sensorineural hearing loss and tinnitus.
  • Any cranial nerve may be affected; vestibulo-cochlear involvement causes tinnitus, vertigo, and ear pain.
5. Gum Pain
  • Oropharyngeal route is a recognized entry point (consumption of unpasteurized dairy, soft cheeses).
  • Lymphadenopathy (cervical, axillary) is present in ~14% of patients, and oropharyngeal/gingival lesions reflect hematogenous seeding or local entry.

Differential Diagnosis to Consider

ConditionFeatures in CommonDistinguishing Against
Typhoid feverFever, malaise, back painNo undulating pattern; rose spots; diarrhea; no joint/ear involvement typically
TuberculosisBack pain, fever, night sweatsProductive cough, more pulmonary signs; lumbar TB causes gibbus/cord compression (rare in brucellosis)
MalariaEvening/night fever, myalgiaCyclical rigors (tertian/quartan); splenomegaly more prominent; no joint/ear/gum features
Infective endocarditisFever, musculoskeletal painHeart murmur, embolic phenomena; Osler nodes
LeptospirosisFever, myalgia, headacheConjunctival suffusion, renal involvement, Weil's disease

Key History Questions to Ask

  1. Occupation: Farmer, veterinarian, abattoir/slaughterhouse worker, laboratory worker?
  2. Diet: Unpasteurized milk, soft goat/sheep cheese (feta, brie), raw/undercooked meat?
  3. Travel: Endemic area (Middle East, Mediterranean, Central Asia, Sub-Saharan Africa, Latin America)?
  4. Animal contact: Cattle, sheep, goats, camels, swine, dogs?
  5. Similar illness in family members (documented in ~50% of household cases in endemic areas)?

Investigations

InvestigationFinding in Brucellosis
Standard Agglutination Test (SAT) / Wright's testTitre ≥ 1:160 is significant; ≥ 1:320 highly suggestive
Blood culture / Bone marrow cultureGold standard; sensitivity 10-85% depending on species; alert lab to biosafety risk
CBCMild anemia, lymphopenia, neutropenia, thrombocytopenia
Liver enzymesMay be mildly elevated (hepatic involvement ~25%)
MRI lumbar spineAnterior end-plate erosions, spondylodiscitis (early finding)
PCR / NAATHighly accurate, rapid; cannot confirm cure
Rose Bengal testRapid screening - sensitive but less specific

Treatment

First-line regimens (per Harrison's 22E and Goldman-Cecil):
Option 1 (WHO preferred):
  • Doxycycline 100 mg BD x 6 weeks + Rifampicin 600-900 mg OD x 6 weeks
Option 2 (for severe/complicated disease - spondylitis, neurobrucellosis):
  • Doxycycline + Streptomycin (or Gentamicin) IM for initial 2-3 weeks, then switch to doxycycline + rifampicin to complete 3-6 months
For neurobrucellosis/spondylitis: Extend total therapy to 3-6 months; add a third agent (co-trimoxazole or fluoroquinolone) for CNS involvement.
"With early antimicrobial therapy, brucellosis is usually cured, and cases of relapsing brucellosis, chronic brucellosis, or localized complications are rare."
  • Goldman-Cecil Medicine

Red Flags Requiring Urgent Evaluation

  • Focal neurological signs (neurobrucellosis - can cause meningitis, encephalitis)
  • Cardiac involvement (Brucella endocarditis - rare but high mortality)
  • Severe thrombocytopenia or pancytopenia
  • Spinal cord compression signs

Sources:
  • Harrison's Principles of Internal Medicine 22E (2025), Chapter 174: Brucellosis
  • Goldman-Cecil Medicine, Chapter 286: Brucellosis
  • Medical Microbiology 9e, Clinical Case 29.3

Management steps

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have everything needed for a complete, step-by-step management plan. Here it is:

Management of Brucellosis - Step-by-Step


STEP 1: CLINICAL ASSESSMENT & RISK STRATIFICATION

History (critical for diagnosis)
  • Occupational exposure: farmer, veterinarian, abattoir worker, lab personnel?
  • Dietary: unpasteurized milk, soft goat/sheep cheese, undercooked meat?
  • Travel to endemic area (Middle East, Mediterranean, South Asia, Africa)?
  • Duration of symptoms (determines acute vs subacute vs chronic classification)
Assess for complications - these change management:
ComplicationClinical Clues
Spondylitis / sacroiliitisSevere back/waist pain - present in this patient
NeurobrucellosisTinnitus, periorbital pain, cranial nerve signs - present in this patient
Orchitis/epididymitisTesticular pain (up to 10% of men)
EndocarditisNew murmur, embolic signs
HepatosplenomegalyAbdominal pain, fullness
This patient has features suggestive of both spondylitis (back/waist pain) and possible neurobrucellosis (tinnitus + periorbital pain) - this classifies him as COMPLICATED brucellosis, requiring longer therapy.

STEP 2: INVESTIGATIONS

Confirm Diagnosis
TestDetails
Serum Agglutination Test (SAT / Wright's test)Titre ≥ 1:160 in endemic areas is presumptive; 4-fold rise over 2 weeks is significant
Rose Bengal testRapid screening - sensitive but less specific
Blood culture x 3Alert lab to Brucella risk (biohazard). Sensitivity 10-85%; Bactec systems positive within 7 days
Bone marrow cultureMore sensitive than blood culture, especially for B. melitensis
PCR (NAAT)Most rapid and sensitive; cannot confirm cure (DNA persists)
IgG/IgM ELISAUseful in chronic/relapsing disease where SAT may be negative
Brucella Coombs testFor chronic cases with negative SAT (detects non-agglutinating antibodies)
Assess Organ Involvement
InvestigationPurpose
CBCAnemia, leukopenia, lymphocytosis, thrombocytopenia
LFTsHepatic involvement (~25% of cases)
ESR, CRPUsually raised in complicated disease
MRI lumbar spineEarly spondylodiscitis: anterior end-plate erosions; paravertebral/psoas abscess
MRI brain + CSFIf neurobrucellosis suspected - lymphocytosis + low glucose in CSF
EchocardiographyIf endocarditis suspected
Isotope bone scanMore sensitive than plain X-ray; positive even after treatment

STEP 3: ANTIMICROBIAL THERAPY

This patient is COMPLICATED (probable spondylitis + neurobrucellosis features) - needs triple therapy and extended duration.

A. Uncomplicated Acute Brucellosis (for reference)

Gold standard (WHO preferred):
  • Doxycycline 100 mg PO BD x 6 weeks + Streptomycin 1 g IM OD x 2-3 weeks
Alternative (more convenient, slightly higher relapse rate ~10-20%):
  • Doxycycline 100 mg PO BD x 6 weeks + Rifampicin 600-900 mg PO OD x 6 weeks
If streptomycin unavailable:
  • Doxycycline 200 mg/day x 6 weeks + Gentamicin 3-5 mg/kg/day IM x 1-2 weeks

B. Complicated Brucellosis - Spondylitis / Sacroiliitis (this patient)

  • Duration extended to 3 months minimum
  • Triple regimen: Doxycycline + Rifampicin + initial Aminoglycoside (Gentamicin x 2 weeks)
  • Monitor MRI spine for response

C. Neurobrucellosis (if confirmed by CSF/MRI)

  • Duration 3-6 months
  • Doxycycline 200 mg/day + Rifampicin 600-900 mg/day + TMP-SMX (co-trimoxazole) for 6+ weeks
  • Can add Ceftriaxone 2 g IV q12h x 6 weeks (substitutes for one oral agent - better CNS penetration)
  • Steroids may be considered in severe neurobrucellosis with inflammation
"Focal neurologic disease due to Brucella requires prolonged treatment for 3-6 months, usually with ceftriaxone supplementation of a standard two-drug regimen." - Harrison's 22E

STEP 4: SUPPORTIVE MANAGEMENT

  • Analgesics / NSAIDs for musculoskeletal pain (back, sacroiliac joints)
  • Bed rest in the acute phase; gradual mobilization
  • Spinal immobilization/bracing if significant spondylodiscitis on MRI
  • Physiotherapy for back pain rehabilitation after acute phase settles
  • Neurology referral if confirmed neurobrucellosis
  • Orthopedics referral if spinal abscess (paravertebral/psoas) requiring surgical drainage

STEP 5: MONITORING & FOLLOW-UP

ParameterSchedule
Clinical reassessmentWeekly for first month
SAT serologyAt 3 months and 6 months; falling titres confirm response
CBC, LFTsMonthly (drug toxicity monitoring - rifampicin hepatotoxicity, doxycycline GI effects)
MRI spine repeatAt 6-8 weeks if spondylitis; document healing
Watch for relapseOccurs in 5-10% with gold-standard regimen; up to 20% with doxycycline + rifampicin
Signs of relapse (usually 2-3 months after completing therapy):
  • Return of fever, sweats, malaise
  • Rising SAT titres
  • Positive blood culture
  • Treat relapse with the same or alternative two-drug regimen for a full 6 weeks

STEP 6: PREVENT COMPLICATIONS & SPECIAL SITUATIONS

SituationAction
Brucella endocarditisBactericidal drugs (fluoroquinolone + aminoglycoside + beta-lactam); early cardiac surgery (valve replacement) - 84% of brucellosis deaths involve endocarditis
Abscess (psoas, paravertebral, splenic)Surgical drainage + antibiotics ≥6 weeks
Prosthetic joint infection~75% need debridement or revision + antibiotics

STEP 7: INFECTION CONTROL & PREVENTION

  • Notify public health authorities (notifiable disease in many countries)
  • Identify source of infection (animal contact, food source)
  • Screen family members and occupational contacts
  • Avoid unpasteurized dairy products going forward
  • Protective equipment if occupational exposure continues

Summary Drug Chart for This Patient

DrugDoseRouteDurationRole
Doxycycline100 mg BDOral3 monthsBackbone
Rifampicin600 mg ODOral3 monthsSecond agent
Gentamicin5 mg/kg/dayIM2 weeks (initial)Third agent / aminoglycoside coverage
Ceftriaxone2 g q12hIV4-6 weeksAdd if neurobrucellosis confirmed
Co-trimoxazole960 mg BDOral3 monthsIf CNS involvement
"Complex or focal disease may necessitate ≥3 months of therapy. Adherence is very important - poor adherence underlies almost all cases of apparent treatment failure." - Harrison's 22E

Sources: Harrison's Principles of Internal Medicine 22E (2025), Ch. 174 | Goldman-Cecil Medicine, Ch. 286 | Red Book 2021 (AAP Committee on Infectious Diseases)
This is a shared conversation. Sign in to Orris to start your own chat.